European urology

• Latest
• Best
• Search…

• European urology · Feb 2016

  Editorial Comment

  Reply from Authors re: Ronald C. Chen. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? Eur Urol 2016;69:211-2: Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patients Receiving Radiation Therapy With or Without Short-term Androgen Deprivation Therapy.

  no abstract available

  read more… or just mark as read…

• European urology · Oct 2015

  Editorial

  Precision and predictive medicine in urothelial cancer: are we making progress?

  Therapy for urothelial carcinoma appears poised for a breakthrough on the basis of information regarding molecular subtypes and promising activity of PD-1/PD-L1 inhibitors. Precision medicine may be possible using rational marker-driven trial designs with enriched information from tumor genotyping and extreme responders.

  read more… mark as read…

• European urology · Sep 2015

  Editorial Comment

  Unorganized prostate-specific antigen-based screening for prostate cancer: more harm than benefit. When will we finally start to implement guidelines and risk assessment tools in clinical practice?

  no abstract available

  read on… mark as read…

• European urology · Sep 2015

  Editorial Comment

  Doing it right: how, not whether, to perform prostate-specific antigen screening.

  no abstract available

  keep going… mark as read…

• European urology · Aug 2015

  Editorial Comment

  The Era of Prostate-specific Antigen-based Personalized Prostate Cancer Screening Has Only Just Begun.

  no abstract available

  expand abstract… or not…